Consonance Capital’s sale of Enclara said to fetch $700 mln-plus valuation

The Philadelphia hospice pharmacy and benefit management provider has received significant inbound interest in recent years.

To read this article, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to read this article and more for free.

Share this